is mounjaro a glp 1 drug Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort More people with type 1

[DOI] [PubMed] [Google Scholar] 8.Kolterman OG, Kim DD, Shen L, Ruggles JA, Nielsen LL, Fineman MS, Baron AD

The existing medications for treating substance use disorder are underutilized and stigmatized, said Fares Qeadan, associate professor of biostatistics at Loyola University in Chicago

however, there is a surprising paucity of reports systematically examining the hypothesis that combined amylin and GLP-1 therapies may provide enhanced suppression in food intake and body weight 43,44

Huang J, Liu Y, Cheng L, Li J, Zhang T, Zhao G, Zhang H

E.EbelingP

Meanwhile, Eli Lilly has issued a warning about compounded tirzepatide that may contain B12 or other additives